Schisandrathera DCAS# 2694046-04-1 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
| Cas No. | 2694046-04-1 | SDF | Download SDF |
| PubChem ID | N/A | Appearance | Powder |
| Formula | C23H32O6 | M.Wt | 404.55 |
| Type of Compound | Lignans | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
Schisandrathera D Dilution Calculator
Schisandrathera D Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.4719 mL | 12.3594 mL | 24.7188 mL | 49.4376 mL | 61.7971 mL |
| 5 mM | 0.4944 mL | 2.4719 mL | 4.9438 mL | 9.8875 mL | 12.3594 mL |
| 10 mM | 0.2472 mL | 1.2359 mL | 2.4719 mL | 4.9438 mL | 6.1797 mL |
| 50 mM | 0.0494 mL | 0.2472 mL | 0.4944 mL | 0.9888 mL | 1.2359 mL |
| 100 mM | 0.0247 mL | 0.1236 mL | 0.2472 mL | 0.4944 mL | 0.618 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Schisanhenol B
Catalog No.:BCX0480
CAS No.:102681-52-7
- Indole-3-acetic acid β-D-glucopyranosyl ester
Catalog No.:BCX0479
CAS No.:19817-95-9
- Gypenoside LXXV
Catalog No.:BCX0478
CAS No.:110261-98-8
- Sinapyl alcohol
Catalog No.:BCX0477
CAS No.:537-33-7
- Rankinidine
Catalog No.:BCX0476
CAS No.:106466-66-4
- Methyl indole-3-acetate
Catalog No.:BCX0475
CAS No.:1912-33-0
- Galanal B
Catalog No.:BCX0474
CAS No.:104113-52-2
- Labda-8(17),12E,14-trien-16,15-olide
Catalog No.:BCX0473
CAS No.:917078-10-5
- Mulberrofuran V
Catalog No.:BCX0472
CAS No.:174423-49-5
- 6'-O-p-Hydroxybenzoylgastrodin
Catalog No.:BCX0471
CAS No.:1551525-70-2
- 15-Hydroxylabda-8(17),12E-dien-16-al
Catalog No.:BCX0470
CAS No.:283614-59-5
- Sanggenol F
Catalog No.:BCX0469
CAS No.:202526-51-0
- Dencichine
Catalog No.:BCX0482
CAS No.:5302-45-4
- Deoxylimonin
Catalog No.:BCX0483
CAS No.:989-23-1
- 5-Methoxydadahol A
Catalog No.:BCX0484
CAS No.:2410566-84-4
- 4-(3-Hydroxydecyl)phenol
Catalog No.:BCX0485
CAS No.:1465124-36-0
- Oxyphyllone D
Catalog No.:BCX0486
CAS No.:1190094-25-7
- Rugulolide A
Catalog No.:BCX0487
CAS No.:3002032-70-1
- Rugulolide B
Catalog No.:BCX0488
CAS No.:3002032-71-2
- 2,4-Dihydroxybezaldehyde
Catalog No.:BCX0489
CAS No.:95-01-2
- Ethyl 2,4-dihydroxybenzoate
Catalog No.:BCX0490
CAS No.:4143-00-4
- 7-epi-α-Cyperone
Catalog No.:BCX0491
CAS No.:547-26-2
- 4-Hydroxy-4-methylcyclohex-2-en-1-one
Catalog No.:BCX0492
CAS No.:70150-56-0
- Sanggenon E
Catalog No.:BCX0493
CAS No.:81381-69-3
ANO1-downregulation induced by schisandrathera D: a novel therapeutic target for the treatment of prostate and oral cancers.[Pubmed:37274097]
Front Pharmacol. 2023 May 18;14:1163970.
Anoctamin 1 (ANO1), a drug target for various cancers, including prostate and oral cancers, is an intracellular calcium-activated chloride ion channel that plays various physiopathological roles, especially in the induction of cancer growth and metastasis. In this study, we tested a novel compound isolated from Schisandra sphenanthera, known as Schisandrathera D, for its inhibitory effect on ANO1. Schisandrathera D dose-dependently suppressed the ANO1 activation-mediated decrease in fluorescence of yellow fluorescent protein; however, it did not affect the adenosine triphosphate-induced increase in the intracellular calcium concentration or forskolin-induced cystic fibrosis transmembrane conductance regulator activity. Specifically, Schisandrathera D gradually decreased the levels of ANO1 protein and significantly reduced the cell viability in ANO1-expressing cells when compared to those in ANO1-knockout cells. These effects could be attributed to the fact that Schisandrathera D displayed better binding capacity to ANO1 protein than the previously known ANO1 inhibitor, Ani9. Finally, Schisandrathera D increased the levels of caspase-3 and cleaved poly (ADP-ribose) polymerase 1, thereby indicating that its anticancer effect is mediated through apoptosis. Thus, this study highlights that Schisandrathera D, which reduces ANO1 protein levels, has apoptosis-mediated anticancer effects in prostate and oral cancers, and thus, can be further developed into an anticancer agent.
Chemical constituents from Schisandra sphenanthera and their cytotoxic activity.[Pubmed:31829042]
Nat Prod Res. 2021 Oct;35(20):3360-3369.
Extensive phytochemical investigation of Schisandra sphenanthera leaves resulted in the isolation of six highly oxygenated nortriterpenoids (1-6) and five lignans (7-11) including a new pre-schisanartane-type, schisandrathera A (1), a new dibenzocyclooctadiene glycoside, schisandrathera B (7) and two new lignans, schisandrathera C (8) and Schisandrathera D (9). Their chemical structures including absolute configurations were determined extensively by means of HR-ESI-MS, NMR, and ECD spectra. In addition, all isolated compounds were tested for cytotoxic activity against PC3 (prostate cancer) and MCF7 (breast cancer) cell lines. Among these compounds, schirubrisin B (3) showed strong cytotoxic effect on both PC3 and MCF7 cell lines with IC(50) values of 3.21 +/- 0.68, 13.30 +/- 0.68 muM, respectively, whereas ten remaining compounds were found to be less effective in the investigated models.
